Available evidence is inconclusive or is inadequate for determining fetal risk when used in pregnant women or women with child bearing potential and nursing mothers.
Therefore, lactitol can be prescribed only if the potential benefits justify the potential risk to the fetus.
Although there have been no studies on the excretion of lactitol in breast milk, it is unlikely that the use of lactitol while breast feeding could have any clinical effect on the child, because its absorption is minimal.
But the potential benefits of drug treatment should be weighed against potential risks before prescribing this drug during lactation.
Other Services
Country
Account